High-ranking U.S. Food and Drug Administration officials opened a multidisciplinary CBD conference on Thursday by saying that the science of CBD and other cannabinoids has become a priority for the agency, considering the wide interest in CBD and the number of products already on the market.
FDA: Science of CBD and other cannabinoids is a ‘priority’ is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
